Indoco Remedies gets USFDA ANDA nod for Glycopyrrolate Injection Medical Dialogues Bureau3 Nov 2019 4:30 AM GMTGlycopyrrolate is indicated for use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions; to reduce the...
Indoco Remedies successfully completes USFDA inspection of CRO Anacipher in Hyderabad Medical Dialogues Bureau13 Aug 2019 4:15 AM GMT"This is the fourth successive USFDA inspection with ZERO 483 for our CRO – AnaCipher," stated Ms Aditi Kare Panandikar, Managing Director, Indoco...
USFDA issues warning letter to Indoco Remedies for Goa plant Medical Dialogues Bureau16 July 2019 6:09 AM GMTThe facility had received six observations in Form 483s and was classified as Official Action Indicated in March. Indoco Remedies responded to these...
Indoco Remedies' new solid dosages facility at Baddi gets UK-MHRA nod Farhat Nasim11 May 2019 4:30 AM GMTIndoco Remedies' new Baddi facility is spread over an area of 18000 sqm, with a manufacturing capacity of 4.3 billion tablets and 50 million capsules...
Indoco Remedies: USFDA retains OAI status for Goa plant Farhat Nasim25 April 2019 4:20 AM GMTIndoco Remedies' spokesperson said that the move is likely to withhold approval of pending abbreviated new drug applications (ANDAs) from Goa...
USFDA inspected Goa facility, no observations issued: Indoco Remedies Farhat Nasim30 March 2019 6:22 AM GMTThe US Food and Drug Administration (USFDA) has cleared the Goa-based sterile manufacturing facility of Indoco Remedies for finished dosages.New...
NPPA fixes retail price of Emcure pharma's HIV drug Meghna A Singhania17 Feb 2019 4:00 AM GMTNew Delhi: Through a recent notice, the drug price regulator National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of Emcure...
NPPA fixes retail price of 29 drug formulations including BP, Cholesterol, pain medications; Details Farhat Nasim30 Jan 2019 6:02 AM GMTThe NPPA order is likely to affect various drug majors including Lupin, Sun Pharmaceuticals, GlaxoSmithKline and Cadila Pharmaceuticals. New Delhi:...
Indoco Remedies gets two minor observations from USFDA for Goa plants Medical Dialogues Bureau25 Nov 2018 3:37 AM GMTMumbai: Drug firm Indoco Remedies on Thursday said it has received two minor observations from the US health regulator for its Goa-based two plants....
